Tridegin, a novel peptidic inhibitor of factor XIIIa from the leech, Haementeria ghilianii, enhances fibrinolysis in vitro

Thrombosis and Haemostasis

Volumn 77, Issue 5, 1997, Pages 959-963

  Seale, Lisa ^a   Finney, Sarah ^a   Sawyer, Roy T ^a   Wallis, Robert B ^a  

^a Biopharm UK Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 13A; FIBRIN; FIBRINOLYTIC AGENT; HEMENTIN; PLASMIN; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR; TRIDEGIN; UNCLASSIFIED DRUG;

ARTICLE; BLOOD CLOT LYSIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CROSS LINKING; DRUG EFFECT; FIBRINOLYSIS; FIBRINOLYTIC THERAPY; HUMAN; LEECH; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE RICH PLASMA;

EID: 0030965350     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1656085     Document Type: Article

References (26)

1. McDonagh J. Structure and function of factor XIII. In: Haemostasis and Thrombosis: Basic Principles and Clinical Practice. Third edition, Colman RW, Hirsh J, Marder VJ, Salzman EW, eds. J B Lippincott Company, Philadelphia, PA 1994; pp 301-13.
2. Schwartz ML, Pizzo SV, Hill RL, McKee PA. The effect of fibrin-stabilizing factor on the subunit structure of human fibrin. J Clin Invest 1971; 50:1506-13.
3. 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis. J Clin Invest 1982; 69: 53642.
4. Jansen JWCM, Haverkate F, Koopman J, Nieuwenhuis HK, Kluft C, Boschman ThAC. Influence of factor XIIIa activity on human whole blood clot lysis in vitro. Thromb Haemost 1987; 57: 171-5.
5. 2-antiplasmin to fibrin is a key factor in regulating blood clot lysis: species differences. Blood Coag Fibrinolysis 1993; 4: 869-75.
6. Francis CW, Marder VJ. Rapid formation of large molecular weight α-polymers in cross-linked fibrin induced by high factor XIII concentrations: role of platelet factor XIII. J Clin Invest 1987; 80: 1459-65.
7. Fukue H, Anderson K, McPhedran P, Clyne L, McDonagh J. A unique factor XIII inhibitor to a fibrin-binding site on factor XIIIA. Blood 1992; 79: 65-74.
8. Finney S, Seale L, Sawyer RT, Wallis RB. Tridegin, a new peptidic inhibitor of factor XIIIa, from the blood sucking leech, Haementeria ghilianii. Biochem J (in press).
9. Sawyer RT, Powell-Jones C, Munro R. The biological function of Hementin in the proboscis of the leech, Haementeria ghilianii. Blood Coag Fibrinolysis 1991; 2: 153-9.
10. Tymiak AA, Tutle JG, Kimball SD, Wang T, Lee VG. A simple and rapid screen for inhibitors of factor XIIIa. J Antibiotics 1993; 46: 204-6.
11. Slaughter TF, Achyuthan KE, Lai T-S, Greenberg CS. A microtitre plate transglutaminase assay utilizing 5′-(biotinamido)pentylamine as substrate. Anal Biochem 1992; 205: 166-71.
12. Swadesh JK, Huang IY, Budzynski AZ. Hementin, a fibrinogenolytic protease from the leech Haementeria ghilianii. J Chromatog 1990; 502: 359-69.
13. Jones AJS, Meunier AM. A precise and rapid microtitre plate clot lysis assay: methodology, kinetic modelling and measurement of catalytic constants for plasminogen activation during fibrinolysis. Thromb Haemost 1990; 64: 455-63.
14. Hauptmann J, Glusa E. Differential effects of staphylokinase, streptokinase and tissue-type plasminogen activator on the lysis of retracted human plasma clots and fibrinolytic plasma parameters in vitro. Blood Coag Fibrinolysis 1995; 6: 579-83.
15. McKee PA, Mattock P, Hill RL. Subunit structure of human fibrinogen, soluble fibrin and cross-linked insoluble fibrin. Proc Natl Acad Sci USA 1970; 66: 738-44.
16. 2-antiplasmin. Thromb Haemost 1992; 68: 315-20.
17. Purves L, Purves M, Brandt W. Cleavage of fibrin-derived D-dimer into monomers by endopeptidase from puff adder venom (Bitis arietans) acting at cross-linked sites of the γ-chain sequence of carboxy terminal cyanogen bromide γ-chain fragments. Biochemistry 1987; 26: 4640-6.
18. Gabriel DA, Muga K, Boothroyd EM. The effect of fibrin structure on fibrinolysis. J Biol Chem 1992; 267: 24259-63.
19. Blomback B, Carlsson K, Hessel B, Liljeborg A, Procyk R, Aslund N. Native fibrin gel networks observed by 3D microscopy, permeation and turbidity. Biochim Biophys Acta 1989; 997: 96-110.
20. Carr ME, Alving BM. Effect of fibrin structure on plasmin-mediated dissolution of plasma clots. Blood Coag Fibrinolysis 1995; 6: 567-73.
21. Budzynski A. Interaction of hementin with fibrinogen and fibrin. Blood Coag Fibrinolysis 1991; 2: 149-52.
22. Malinconico SM, Katz JB, Budzynski AZ. Fibrinogen degradation by hementin, a fibrinogenolytic anticoagulant from the salivary glands of the leech Haementeria ghilianii. J Lab Clin Med 1984; 104: 842-54.
23. Sprengers ED, Kluft C. Plasminogen activator inhibitors. Blood 1987; 69: 381-7.
24. Munro R, Powell-Jones C, Sawyer RT. Effects of hementin on fibrinogen mediated platelet aggregation/deaggregation in vitro. Platelets 1991; 2: 55-6.
25. Shebuski RJ, Sitko GR, Claremon DA, Baldwin JJ, Remy DC, Stern AM. Inhibition of factor XIIIa in a canine model of coronary thrombosis: effect on reperfusion and acute reocclusion after recombinant tissue-type plasminogen activator. Blood 1990; 75: 1455-9.
26. Leidy EM, Stern AM, Friedman PA, Bush LR. Enhanced thrombolysis by a factor XIIIa inhibitor in a rabbit model of femoral artery thrombosis. Thromb Res 1990; 59: 15-26.